InsiderClue
Insiders · Profile

Shah Jatin

EVP, Chief Medical Officer at Karyopharm Therapeutics. Filing since 19 Feb 2020. CIK 0001782186

Company
Date
Role
Action
Shares
Amount
Of holding
KPTI Karyopharm Therapeutics Inc.
17 Feb 2022
EVP, Chief Medical Officer
Sold, plan not stated
1,306
$15.83K
1.0%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2022
EVP, Chief Medical Officer
Sold, plan not stated
1,704
$16.80K
1.3%
KPTI Karyopharm Therapeutics Inc.
7 May 2021
EVP, Chief Medical Officer
Bought
23,250
$199.99K
21.4%
KPTI Karyopharm Therapeutics Inc.
18 Feb 2021
EVP, Chief Medical Officer
Sold, plan not stated
1,186
$17.59K
2.2%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
EVP, Chief Medical Officer
Sold, plan not stated
1,748
$27.13K
3.5%
KPTI Karyopharm Therapeutics Inc.
15 Jul 2020
EVP, Chief Medical Officer
Sold, plan not stated
589
$11.46K
1.3%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
EVP, Chief Medical Officer
Sold, plan not stated
1,375
$22.66K
3.3%
7 decisions on file.